首页> 美国卫生研究院文献>Hepatitis Monthly >Optimal Duration of Treatment for HCV Genotype 1 Infection in Slow Responders: A Meta-Analysis

【2h】

Optimal Duration of Treatment for HCV Genotype 1 Infection in Slow Responders: A Meta-Analysis

机译：慢反应者中HCV基因1型感染的最佳治疗持续时间：荟萃分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

获取外文期刊封面目录资料

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

BackgroundA head-to-head comparison of the 72-week and 48-week anti-HCV therapies in slow responders with genotype 1 infection has been performed in several randomized clinical trials (RCTs).

机译：背景技术在几项随机临床试验（RCT）中，已对基因1型感染的慢反应者进行72周和48周抗HCV治疗的正面对照。

著录项

期刊名称 Hepatitis Monthly
作者
Seyed Moayed Alavian; Seyed Vahid Tabatabaei; Bita Behnava; Nastaran Mahboobi;
展开▼
作者单位

展开▼
年(卷),期 2011(11),8
年度 2011
页码 612–619
总页数 8
原文格式 PDF
正文语种
中图分类肠道病毒与肝炎病毒;肝及胆疾病;肠疾病;
关键词
Hepatitis C virus Genotype Treatments;

机译：丙型肝炎病毒;基因型;治疗;

相似文献

外文文献
中文文献
专利

1. OPTIMAL DURATION OF TREATMENT FOR HCV GENOTYPE 1 INFECTION IN SLOW RESPONDERS: A META-ANALYSIS [J] . ALAVIAN SEYED MOAYED, TABATABAEI SEYED VAHID, BEHNAVA BITA, Hepatitis Monthly . 2011,第8期

机译：慢反应者丙型肝炎病毒基因1型感染治疗的最佳持续时间：一种meta分析
2. Interleukin 28B genetic polymorphisms play a minor role in identifying optimal treatment duration in HCV genotype 1 slow responders to pegylated interferon plus ribavirin [J] . LiuC.-H., LiangC.-C., LiuC.-J., Antiviral therapy . 2012,第6期

机译：白介素28B遗传多态性在确定聚乙二醇干扰素加利巴韦林的HCV基因型1慢反应者的最佳治疗持续时间中起次要作用
3. Should Patients With Hepatitis C Genotype 2/3 Infection Who Are Slow Responders to Pegylated Interferon/Ribavirin Have Treatment Duration Extended? [J] . Carla Silva, Elizabeth Ianna, Tracey Jones, Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2015,第2期

机译：对聚乙二醇化干扰素/利巴韦林反应较慢的丙型肝炎基因型2/3感染患者是否应延长治疗时间？
4. Influence of hepatitis C virus genotypes and F protein on outcome of HCV infection among injection drug users [C] . Yun Zhang, Jingjing Yang, Haopeng Wang, International symposium on pharmacogenomics and the regulation of drug metabolism enzymes and genes. . 2010

机译：丙型肝炎病毒基因型和F蛋白对注射吸毒者HCV感染结局的影响
5. Hepatitis C infection in injection drug users from southern China: Low viral clearance, multiple genotypes and mixed genotype infections. [D] . Garten, Rebecca JoAnne. 2005

机译：中国南部注射吸毒者的丙型肝炎感染：病毒清除率低，多种基因型和混合基因型感染。
6. The Successful Retreatment with Glecaprevir and Pibrentasvir of Genotype 1 or 2 HCV-infected Hemodialysis Patients who Failed to Respond to NS5A and Protease Inhibitor Treatment [O] . Goki Suda, Masato Nakai, Takuya Sho, 2019

机译：用Glecaprevir和Pibrentasvir成功治疗基因型1或2的HCV感染的血液透析患者但对NS5A和蛋白酶抑制剂治疗无效
7. Optimal Duration of Treatment for HCV Genotype 1 Infection in Slow Responders: A Meta-Analysis [O] . Alavian, Seyed Moayed, Tabatabaei, Seyed Vahid, Behnava, Bita, 2011

机译：慢反应者中HCV基因1型感染的最佳治疗持续时间：荟萃分析
8. Compounds, Methods and Compositions Useful for the Treatment of Bovine Viral Diarrhea Virus (BVDV) Infection and Hepatitis C Virus (HCV) Infection. [R] . Dykstra, C. C., Givens, M. D., Stringfellow, D. A., 2005

机译：可用于治疗牛病毒性腹泻病毒（BVDV）感染和丙型肝炎病毒（HCV）感染的化合物，方法和组合物。

Optimal Duration of Treatment for HCV Genotype 1 Infection in Slow Responders: A Meta-Analysis

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅